Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03856372 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

StatusCompleted
PhaseNot applicable
Started2018-09-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-02
Study Status, Study Design, Contacts/Locations v1
Trial completed
Primary completion confirmed: August 2022 (last estimated September 2023)
Primary completion dateestimated 2023-09-30→confirmed 2022-08-30
Completion dateestimated 2028-10-30→confirmed 2022-08-30
Study sitesdetails revised at 3 of 3 sites
2019-02-25
Original filing
Fudan University
624 trials monitored
See 9 trials at risk
Breast Cancer
5,180 trials monitored
See 256 trials at risk
The study was designed to investigate whether hypofractionated adjuvant radiotherapy is noninferior to conventionally fractionated adjuvant radiotherapy in terms of efficacy and toxicities for high risk breast cancer patients treated with mastectomy
Trial Details
NCT Number NCT03856372
Lead Sponsor Fudan University
Conditions Breast Cancer
Enrollment 1,494 participants
Start Date 2018-09-01
Primary Completion 2022-08-30 (estimated)
Study Completion 2022-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-03